会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 68. 发明申请
    • HUMIDIFIER WITH FIELD RECONFIGURABLE BYPASS FEATURE
    • 带现场可重复旁路功能的加湿器
    • US20110068488A1
    • 2011-03-24
    • US12565706
    • 2009-09-23
    • XinHua CaoStephane Joseph Pierre BelandBin WangJason AbleitnerBrad TerlsonEvelyne TremblayVincent Boutin
    • XinHua CaoStephane Joseph Pierre BelandBin WangJason AbleitnerBrad TerlsonEvelyne TremblayVincent Boutin
    • B01F3/04F24F6/02F23L13/00
    • F24F6/043F24F11/0008F24F11/30F24F2110/20Y10S261/15
    • A humidifier for adding humidity to an air stream of an HVAC system includes a housing configured to be mounted to a surface of an HVAC duct. A back side of the housing may be positioned adjacent to an opening in the surface of the HVAC duct, and the housing may be configured to hold a humidifier pad in an operating position. The housing may define a first air flow path from a first side of the humidifier pad to the opening in the surface of the HVAC duct when the housing is mounted to the surface of the HVAC duct. The housing may further define a second air flow path from a second side of the humidifier pad to a bypass aperture. At least part of the second air flow path may be defined by a bypass duct member. The bypass duct member may be field-reconfigurable between at least a first position resulting in the bypass aperture being located at a first location, and a second position resulting in the bypass aperture being located at a second location. In some cases, the first and second locations are on the left and right sides, respectively, of the humidifier housing.
    • 用于向HVAC系统的空气流添加湿度的加湿器包括构造成安装到HVAC管道的表面的壳体。 壳体的后侧可以邻近于HVAC管道的表面中的开口定位,并且壳体可以被配置为将加湿器垫保持在操作位置。 当壳体安装到HVAC管道的表面时,壳体可以限定从加湿器衬垫的第一侧到HVAC管道的表面中的开口的第一空气流动路径。 壳体还可以限定从加湿器垫的第二侧到旁路孔的第二空气流动路径。 第二气流路径的至少一部分可以由旁路管道构件限定。 旁路管道构件可以在导致旁路孔位于第一位置的至少第一位置和导致旁路孔位于第二位置的第二位置之间进行场重新配置。 在一些情况下,第一和第二位置分别位于加湿器壳体的左侧和右侧。
    • 69. 发明申请
    • MULTIPLE ANTENNA MODE CONTROL METHOD BASED ON STATION
    • 基于站点的多天线模式控制方法
    • US20100189030A1
    • 2010-07-29
    • US12442945
    • 2007-09-18
    • Feng LiLi ZhangBin Wang
    • Feng LiLi ZhangBin Wang
    • H04W4/00H04L1/02
    • H04B7/0691H04B7/0628H04B7/0689H04B7/0874
    • The present invention provides a multiple antenna mode control method based on Station, including the steps: step 1 the Station reports a multiple antenna mode set or subset supported by the Station to the Access Point; step 2, the Access Point returns a multiple antenna mode set or subset supported by the Access Point to the Station, or returns directly a multiple antenna mode set or subset supported by both the Station and the Access Point to the Station; and step 3, a multiple antenna mode is chosen from a multiple antenna mode set or subset supported by both the Station and the Access Point for communicating between the Station and the Access Point. Thereby, a best transmission quality can be achieved during data transmission, and furthermore, the retransmission times and the error frame rate are reduced, and the network throughput is decreased.
    • 本发明提供一种基于站的多天线模式控制方法,包括以下步骤:步骤1,台站向接入点报告站点支持的多天线模式集或子集; 步骤2,接入点将接入点支持的多天线模式集或子集返回到站,或直接返回站和接入点支持的多天线模式集或子集到站; 并且步骤3,从站和接入点所支持的多天线模式集或子集中选择多天线模式,以在站和接入点之间进行通信。 因此,在数据传输期间可以实现最佳的传输质量,此外,重传次数和错误帧速率降低,网络吞吐量降低。
    • 70. 发明申请
    • VACCINE PREVENTING AND/OR TREATING AUTOIMMUNE DISEASES
    • 疫苗预防和/或治疗自身免疫性疾病
    • US20100143401A1
    • 2010-06-10
    • US12532643
    • 2008-03-19
    • Bin WangHuali JinYoumin KangWenjuan ZhangYang YuJinyao Li
    • Bin WangHuali JinYoumin KangWenjuan ZhangYang YuJinyao Li
    • A61K39/00A61P37/04A61P3/10
    • A61K39/0008A01K2267/0325A61K2039/53A61K2039/545
    • The present invention discloses a vaccine preventing and/or treating autoimmune diseases. Its active component is: the mixture consisting of a protein antigen causing an autoimmune disease or the epitope polypeptides thereof, and the recombinant eukaryotic vector with the coding genes of an autoantigen or the epitope polypeptides thereof inserted into multiple cloning sites. The autoantigen is insulin, glutamic acid decarboxylase or heat shock protein, myelin oligodendrocyte glycoprotein, two myelin antigens, zona pellucida 3, myoglobulin, type II collagen, thyroglobulin, cell membrane surface antigen, type II colloid antigen, acetylcholine receptor, thyrocyte cell surface antigen, salivary gland duct antigen, thyroglobulin, superantigen, or interphotoreceptor retinoid binding protein. The vaccine can inhibit the proliferation of T cells of immune animals and humans, induce the occurrence of immune suppression, as well as prevent and/or treat autoimmune diseases effectively.
    • 本发明公开了一种预防和/或治疗自身免疫疾病的疫苗。 其活性组分是:由引起自身免疫疾病的蛋白质抗原或其表位多肽组成的混合物和具有插入到多个克隆位点中的自身抗原或其表位多肽的编码基因的重组真核载体。 自身抗原是胰岛素,谷氨酸脱羧酶或热休克蛋白,髓鞘少突胶质细胞糖蛋白,两种髓鞘抗原,透明带3,肌球蛋白,II型胶原,甲状腺球蛋白,细胞膜表面抗原,II型胶体抗原,乙酰胆碱受体,甲状腺细胞表面抗原 ,唾液腺导管抗原,甲状腺球蛋白,超抗原或视网膜受体类视黄醇结合蛋白。 疫苗可以抑制免疫动物和人类的T细胞的增殖,诱导免疫抑制的发生,以及有效地预防和/或治疗自身免疫性疾病。